HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ran Liu Selected Research

Stents

2/2022Pre-procedural color duplex ultrasound evaluation predicts restenosis after long-segment superficial femoral artery stenting.
1/2020Efficacy and safety of switching from ticagrelor to clopidogrel during the early and late phase in acute coronary syndrome patients after percutaneous coronary intervention.
6/2019Arterial occlusions increase the risk of in-stent restenosis after vertebral artery ostium stenting.
3/2019Dual Antiplatelet Therapy: How Long Is Long Enough?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ran Liu Research Topics

Disease

96Neoplasms (Cancer)
05/2024 - 11/2008
26Inflammation (Inflammations)
05/2024 - 01/2002
21Infections
03/2024 - 01/2015
20Ischemic Stroke
02/2024 - 05/2004
20Esophageal Squamous Cell Carcinoma
01/2024 - 10/2007
19Stroke (Strokes)
02/2024 - 10/2002
16Esophageal Neoplasms (Esophageal Cancer)
04/2024 - 01/2012
15Ischemia
05/2024 - 01/2002
14Carcinogenesis
11/2023 - 01/2012
13Fibrosis (Cirrhosis)
07/2023 - 10/2016
13Hemorrhage
05/2023 - 03/2010
11Brain Ischemia (Cerebral Ischemia)
01/2023 - 12/2003
9Reperfusion Injury
01/2023 - 01/2002
9Leukemia
01/2023 - 01/2010
9Alzheimer Disease (Alzheimer's Disease)
11/2022 - 05/2004
8Lung Neoplasms (Lung Cancer)
09/2023 - 03/2016
8Breast Neoplasms (Breast Cancer)
10/2022 - 02/2012
7Neoplasm Metastasis (Metastasis)
04/2024 - 01/2012
7COVID-19
04/2024 - 01/2020
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2023 - 03/2016
7Transient Ischemic Attack
06/2014 - 05/2004
6Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
11/2012 - 07/2003
5Liver Neoplasms (Liver Cancer)
11/2023 - 08/2013
5Hepatocellular Carcinoma (Hepatoma)
11/2023 - 02/2013
5Carcinoma (Carcinomatosis)
11/2023 - 01/2010
5Infarction (Infarctions)
12/2017 - 01/2002
4Pain (Aches)
01/2023 - 01/2014
4Wounds and Injuries (Trauma)
02/2022 - 01/2002
4Hypertension (High Blood Pressure)
12/2021 - 01/2013
4Hypoxia (Hypoxemia)
01/2020 - 04/2012
4Glioma (Gliomas)
10/2017 - 11/2008
3Brain Edema (Cerebral Edema)
03/2024 - 12/2012
3Brain Injuries (Brain Injury)
03/2024 - 01/2002
3Nervous System Diseases (Neurological Disorders)
02/2024 - 01/2012
3Rhabdomyolysis
01/2024 - 01/2017
3Cardiovascular Diseases (Cardiovascular Disease)
12/2023 - 01/2018
3Colitis
11/2023 - 02/2008
3Stomach Neoplasms (Stomach Cancer)
01/2023 - 01/2019
3Necrosis
01/2023 - 04/2005
3Myasthenia Gravis
01/2023 - 01/2022

Drug/Important Bio-Agent (IBA)

41Biomarkers (Surrogate Marker)IBA
03/2024 - 01/2010
34Proteins (Proteins, Gene)FDA Link
04/2024 - 05/2004
17MicroRNAs (MicroRNA)IBA
08/2021 - 01/2012
15Glucose (Dextrose)FDA LinkGeneric
04/2024 - 04/2012
13Estrogens (Estrogen)FDA Link
09/2017 - 01/2002
11Neuroprotective AgentsIBA
01/2017 - 07/2003
10CytokinesIBA
01/2024 - 01/2002
9PolyaminesIBA
01/2018 - 01/2011
8NitrosaminesIBA
01/2024 - 11/2019
8Messenger RNA (mRNA)IBA
11/2023 - 10/2007
8Therapeutic UsesIBA
09/2023 - 05/2004
7PlatinumIBA
01/2023 - 03/2013
7Oxaliplatin (Eloxatin)FDA LinkGeneric
06/2017 - 03/2013
6Transcription Factors (Transcription Factor)IBA
05/2024 - 08/2014
6Rituximab (Mabthera)FDA Link
04/2024 - 10/2019
6Indicators and Reagents (Reagents)IBA
11/2023 - 01/2020
5LipidsIBA
12/2023 - 07/2017
5EnzymesIBA
11/2023 - 01/2010
5AlbuminsIBA
09/2023 - 05/2020
5DNA (Deoxyribonucleic Acid)IBA
03/2023 - 01/2013
5SteroidsIBA
05/2021 - 12/2003
5Estradiol (Delestrogen)FDA LinkGeneric
01/2021 - 12/2003
5CollagenIBA
01/2021 - 01/2013
5Daunorubicin (Cerubidine)FDA LinkGeneric
01/2019 - 01/2011
5glecaprevir and pibrentasvirIBA
01/2018 - 01/2017
4Interleukin-6 (Interleukin 6)IBA
03/2024 - 01/2018
4SphingolipidsIBA
01/2024 - 07/2019
4Drinking WaterIBA
01/2024 - 11/2019
4IronIBA
01/2024 - 02/2010
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2023 - 01/2018
4cyanoginosin LR (microcystin LR)IBA
12/2023 - 10/2022
4Phospholipids (Phosphatides)FDA LinkGeneric
09/2023 - 04/2013
4Fibrinogen (Factor I)FDA Link
02/2023 - 11/2012
4Air Pollutants (Pollutants, Air)IBA
01/2023 - 01/2021
4Retinaldehyde (Retinal)IBA
05/2021 - 07/2003
43' Untranslated Regions (3' UTR)IBA
02/2019 - 11/2009
4Caspase 3 (Caspase-3)IBA
01/2019 - 06/2008
4AntibodiesIBA
01/2018 - 02/2010
4glecaprevirIBA
01/2018 - 10/2016
4Matrix Metalloproteinases (MMPs)IBA
04/2011 - 01/2002
3CateninsIBA
05/2024 - 11/2023
3Glutamic Acid (Glutamate)FDA Link
02/2024 - 01/2002
3MetalsIBA
01/2024 - 01/2022
3HDL LipoproteinsIBA
01/2024 - 03/2016
3LigandsIBA
12/2023 - 11/2007
3Tryptophan (L-Tryptophan)FDA Link
11/2023 - 10/2020
3Untranslated RNA (Noncoding RNA)IBA
11/2023 - 01/2018
3RNA (Ribonucleic Acid)IBA
11/2023 - 12/2016
3TabletsIBA
09/2023 - 10/2020
3Brain-Derived Neurotrophic Factor (BDNF)IBA
02/2023 - 01/2022
3CopperIBA
02/2023 - 12/2021
3Triglycerides (Triacylglycerol)IBA
01/2023 - 01/2020
3Morphine (MS Contin)FDA LinkGeneric
01/2023 - 01/2014
3Peptides (Polypeptides)IBA
10/2022 - 01/2018

Therapy/Procedure

45Therapeutics
01/2024 - 01/2002
13Drug Therapy (Chemotherapy)
12/2023 - 01/2011
8Chinese Traditional Medicine (Traditional Chinese Medicine)
09/2023 - 04/2013
4Stents
02/2022 - 03/2019
4Aftercare (After-Treatment)
01/2019 - 01/2012
3Thrombectomy
10/2022 - 01/2021